Target Prioritization on BRAF inhibitor case study A375 cell line, Vemurafenib
1Target RankPBIO-AGENT-8B
Evaluation results
| Method | Links | |||
|---|---|---|---|---|
| PBIO-AGENT-8B2026.02 | 1 | 0.177 | 64.6 | |
| Llama-3-8B2026.02 | 2 | 0.029 | 5.1 | |
| Qwen3-30B-A3B2026.02 | 2 | -0.025 | -28.1 |
| Method | Links | |||
|---|---|---|---|---|
| PBIO-AGENT-8B2026.02 | 1 | 0.177 | 64.6 | |
| Llama-3-8B2026.02 | 2 | 0.029 | 5.1 | |
| Qwen3-30B-A3B2026.02 | 2 | -0.025 | -28.1 |